Cancer News and Research

Latest Cancer News and Research

Scientists develop new combined treatment method for skin cancer prevention

Scientists at The University of Texas Health Science Center San Antonio are on to something that should bring joy to sunbathers everywhere. Studies show that certain plant substances, administered in combinations, have the ability to suppress skin cancer development in susceptible mice.

30 Aug 2010

Promising skin cancer drug in the near horizon

A new drug has been developed to combat a deadly form of skin cancer – melanoma. The drug, PLX4032, was tested on 32 melanoma patients who had a key mutation in their tumors. 26 of these patients responded favorably says the study published in the New England Journal of Medicine.

30 Aug 2010

Eight signs of cancer: Study

Scientists have now identified eight signs of cancer that need immediate attention. These can predict the risk of cancer with such accuracy in certain age groups that patients should be referred to a specialist straight away unless there is a good explanation that is is something else.

30 Aug 2010

Roughly one in six cancer survivors forgo some medical care due to cost, Study finds

Two years after undergoing a double mastectomy and chemotherapy so severe she was hospitalized in intensive care for several weeks, breast cancer survivor Denise Hicks should be following what her doctors call 'the plan' which includes additional medications and treatments.

30 Aug 2010

Scientists identify genetic basis to determine severity of allergic asthma in experimental models

Scientists have identified a genetic basis for determining the severity of allergic asthma in experimental models of the disease.The study may help in the search for future therapeutic strategies to fight a growing medical problem that currently lacks effective treatments, researchers from Cincinnati Children's Hospital Medical Center report in the Aug. 29 Nature Immunology.

30 Aug 2010

Researchers recommend action to reverse federal court decision on embryonic stem cell research ban

Against a backdrop of some of the world's most sophisticated biological research labs, Rep. Steve Israel (D-Huntington) this morning issued a challenge to his colleagues in Congress immediately upon their return from summer recess, he urged, they should pass legislation that would reverse a recent Federal court decision that has brought embryonic stem cell research in the U.S. to a screeching halt.

30 Aug 2010

Doctors' religious beliefs affect how they provide end-of-life care, Study finds

A doctor's own religious practice can become quite relevant to patient care, especially when end of life issues come into play. A new study finds that doctors who are not religious are more likely to take steps to help end a very sick patient's life, and to discuss these kinds of decisions, than doctors who are very religious.

30 Aug 2010

International conference to address clinical research in Europe

Journalists are invited to attend the one-day conference on the "Future of independent academic clinical research in Europe", which is being organised under the auspices of the Belgian Presidency of the European Union and with support of both the academies of medicine in Brussels.

30 Aug 2010

Cigarettes as mood enhancers increase risk of depression

While some teenagers may puff on cigarettes to 'self-medicate' against the blues, scientists at the University of Toronto and the University of Montreal have found that smoking may actually increase depressive symptoms in some adolescents. Published in the journal Addictive Behaviors, the findings are part of the long-term Nicotine Dependence in Teens (NDIT) study based at the University of Montreal Hospital Research Centre.

27 Aug 2010

Recent releases in Global Health

"[N]ew diagnostic techniques [for tuberculosis] need to be studied in children," according to a Lancet Infectious Diseases Reflection. "Tuberculosis is an important cause of morbidity and mortality in children worldwide, but estimates of disease burden are inaccurate because most cases are not confirmed," the author writes. He discusses a study published in the same issue that examines various methods for diagnosing TB in children.

27 Aug 2010

Merck's initiation of IMO-2055 Phase 1b clinical trial in SCCHN triggers €3.0M milestone payment to Idera

Idera Pharmaceuticals, Inc., today announced that it has achieved a milestone under its worldwide licensing and collaboration agreement with Merck KGaA, Darmstadt, Germany. The milestone was achieved upon Merck KGaA's initiation of a Phase 1b clinical trial of IMO-2055 (EMD 1201081), an agonist of Toll-like Receptor 9 (TLR9), in combination with cisplatin, fluorouracil and cetuximab (Erbitux®) in first-line treatment of patients with squamous cell carcinoma of the head and neck (SCCHN).

27 Aug 2010

FDA approves Novartis' Tekamlo for treatment of high blood pressure

The US Food and Drug Administration (FDA) approved Tekamlo™ (aliskiren and amlodipine) tablets, a single-pill for the treatment of high blood pressure combining the only approved direct renin inhibitor, Tekturna® (aliskiren), with the widely used calcium channel blocker amlodipine. Tekamlo is approved as initial therapy for patients who are likely to need multiple drugs to achieve their blood pressure goals, and as replacement therapy for patients whose blood pressure is not adequately controlled with either aliskiren or amlodipine alone.

27 Aug 2010

Research: Impact of seafood components on human health

Seafood has an enormous potential to promote health. At the same time the opportunities for innovation and value creation are huge. Knowledge and documentation are the keys to success.

27 Aug 2010

APF offers actionable solutions to improve access to pain care

The American Pain Foundation (APF), the nation's largest consumer advocacy organization for people in pain, released today a position statement imploring the medical community, regulators and concerned stakeholders to reaffirm their ethical commitment to the 76.5 million Americans—or one in four people—who struggle with pain, work collaboratively to improve access to pain care and dismantle the barriers preventing timely, appropriate and effective pain care for millions.

27 Aug 2010

World's tallest man undergoes Gamma Knife surgery

Much of Sultan Kosen's eight feet, two-inch stature rose up in an 17-year period starting at age 10, when the benign tumor in his brain's pituitary gland highjacked the organ, causing it to secrete massive amounts of growth hormone, making Mr. Kosen's body grow fast and grow without ceasing. He will need to wait several months to find out if his Gamma Knife® surgery last Thursday at the University of Virginia (UVA, Charlottesville, Va.) has inactivated the tumor and he has reached his final height, but his physicians are optimistic.

27 Aug 2010

Genentech receives FDA Refuse to File letter for accelerated approval of trastuzumab-DM1 BLA

ImmunoGen, Inc., a biotechnology company that develops antibody-based targeted anticancer products, today announced that Genentech, a member of the Roche Group, today announced its receipt of a Refuse to File (RTF) letter from the US Food and Drug Administration (FDA) for the accelerated approval of the Biologic License Application (BLA) for trastuzumab-DM1, or T-DM1, submitted in July 2010.

27 Aug 2010

'Molecular Diagnostics Europe' conference debuts at BIOTECHNICA 2010

BIOTECHNICA, Europe's Leading Exhibition for Biotechnology and Life Sciences, is broadening its portfolio to include a new conference and special display on molecular diagnostics. Produced by the Cambridge Healthtech Institute, a leading organizer of biomedical conferences in the United States, the "Molecular Diagnostics Europe" (MDxEU) conference is making its debut this year. The main focus will be on new methods for molecular diagnostics, particularly with regard to cancer and infectious diseases.

27 Aug 2010

Second-hand smoke triggers complex inflammatory response

Second-hand smoke is associated with a number of diseases and conditions, including cancer, heart disease, and emphysema. It is an irritant to lung tissue and blood vessels, but the processes through which the body reacts to second-hand smoke comprise a mystery scientists are only beginning to unravel. Researchers at the University of Colorado-Denver are currently studying how second-hand smoke affects the lungs of rats, and so far it appears that second-hand smoke triggers a complex inflammatory response.

27 Aug 2010

Assurant Employee Benefits announces new employee-paid, voluntary benefits

Assurant Employee Benefits now offers cancer, critical illness, accident and gap insurance as employee-paid, voluntary benefits. These products provide competitive benefits backed by Assurant Employee Benefits' commitment to customer service. Initially available in 16 states, these products will be introduced to additional markets throughout the year.

27 Aug 2010

Cord Blood America announces Quality Service Guarantee for stem cell engraft

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced a $50,000 Quality Service Guarantee.

27 Aug 2010

Cancer News and Research

Latest Cancer News and Research

Scientists develop new combined treatment method for skin cancer prevention

Promising skin cancer drug in the near horizon

Eight signs of cancer: Study

Roughly one in six cancer survivors forgo some medical care due to cost, Study finds

Scientists identify genetic basis to determine severity of allergic asthma in experimental models

Researchers recommend action to reverse federal court decision on embryonic stem cell research ban

Doctors' religious beliefs affect how they provide end-of-life care, Study finds

International conference to address clinical research in Europe

Cigarettes as mood enhancers increase risk of depression

Recent releases in Global Health

Merck's initiation of IMO-2055 Phase 1b clinical trial in SCCHN triggers €3.0M milestone payment to Idera

FDA approves Novartis' Tekamlo for treatment of high blood pressure

Research: Impact of seafood components on human health

APF offers actionable solutions to improve access to pain care

World's tallest man undergoes Gamma Knife surgery

Genentech receives FDA Refuse to File letter for accelerated approval of trastuzumab-DM1 BLA

'Molecular Diagnostics Europe' conference debuts at BIOTECHNICA 2010

Second-hand smoke triggers complex inflammatory response

Assurant Employee Benefits announces new employee-paid, voluntary benefits

Cord Blood America announces Quality Service Guarantee for stem cell engraft

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in